⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRZN News
Surrozen, Inc. Common
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
globenewswire.com
SRZN
Surrozen to Present at Upcoming Healthcare Investor Conferences
globenewswire.com
SRZN
Form 8-K
sec.gov
SRZNW
SRZN
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
SRZN
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
SRZN
Surrozen to Present at Upcoming Healthcare Investor Conference
globenewswire.com
SRZN
Form 8-K
sec.gov
SRZNW
SRZN
Surrozen to Present at Upcoming Healthcare Investor Conference
globenewswire.com
SRZN
Form 8-K
sec.gov
SRZN
SRZNW
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
SRZN